Breakthrough Targeting Method for Healthcare Industry Honored by Business Intelligence Group

Dstillery, the leading custom audience solutions company, announced that its Custom Patient Targeting solution had been named a winner in the Artificial Intelligence Excellence Awards program operated by The Business Intelligence Group. The business awards program aims to recognize organizations, products, and people who bring AI to life and apply it to solve real problems.

Powered by Dstillery’s patented ID-free® targeting technology, Custom Patient Targeting is a privacy-safe advertising solution designed to help healthcare brands reach their patients. The solution works within data-strict healthcare regulations, complies with current and new US national and state privacy laws and policies, and adheres to HIPAA, NAI, and DSP guidelines. Custom Patient Targeting’s AI-powered predictive modeling offers greater precision than many ID-dependent solutions healthcare brands have historically used.

Marketing Technology News: MarTech Interview with Dmitry Kudrenko, CEO at Stripo

“Custom Patient Targeting meets these challenges by delivering targeting without any user tracking or profiles,” said Michael Beebe, CEO of Dstillery. “We are thrilled to be recognized for our innovation which allows healthcare marketers to reach the right patients and honor the highest standard of privacy,” he added.

Unlike anything on the market, Custom Patient Targeting uses AI-powered predictive modeling, ICD-10-specific information from claims data, and search data from anonymized opted-in panels to build a condition-specific model that targets ad impressions based on aggregated patient behavior. Dstillery’s innovative technique also employs privacy-safe signals like domain, geo, and time-of-day to pinpoint the moment most likely to engage the patient. This multi-signal approach helps to focus a healthcare brand’s budget on reaching the right patients.

Marketing Technology News: How “New Bing” & ChatGPT Can Create Smarter, More Targeted Advertising with First-Party Data

Last year, Dstillery further strengthened Custom Patient Targeting’s precision by partnering with healthcare data analytics company, PurpleLab. Via Purple Lab’s anonymized database, the solution leverages 40 billion medical and pharmacy claims, capturing comprehensive coverage of the entire US population and 98% of payer data.

“We are so proud to name Dstillery as a winner in our inaugural Artificial Intelligence Excellence Awards program,” said Maria Jimenez, Chief Nominations Officer for Business Intelligence Group. “Congratulations to the entire team!”